Gene · 56034
Papers1,955
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,955
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The multifaceted role of placental growth factor in the pathogenesis and progression of bronchial asthma and pulmonary fibrosis: Therapeutic implications. | Genes Dis | 2023 | 37397552 | PubTator, text mining | PubMed |
| Clinical progress of anti-angiogenic targeted therapy and combination therapy for gastric cancer. | Front Oncol | 2023 | 37384288 | PubTator, text mining | PubMed |
| Aptamers Versus Vascular Endothelial Growth Factor (VEGF): A New Battle against Ovarian Cancer. | Pharmaceuticals (Basel) | 2023 | 37375796 | PubTator, text mining | PubMed |
| Tocotrienol-Rich Fraction Ameliorates the Aluminium Chloride-Induced Neurovascular Dysfunction-Associated Vascular Dementia in Rats. | Pharmaceuticals (Basel) | 2023 | 37375775 | PubTator, text mining | PubMed |
| Angiogenesis and Hepatocellular Carcinoma: From Molecular Mechanisms to Systemic Therapies. | Medicina (Kaunas) | 2023 | 37374319 | PubTator, text mining | PubMed |
| Emerging roles of ferroptosis-related miRNAs in tumor metastasis. | Cell Death Discov | 2023 | 37369681 | PubTator, text mining | PubMed |
| Anterior blepharitis is associated with elevated plectin levels consistent with a pronounced intracellular response. | Ocul Surf | 2023 | 37348651 | PubTator, text mining | PubMed |
| TCGA Expression Analyses of 10 Carcinoma Types Reveal Clinically Significant Racial Differences. | Cancers (Basel) | 2023 | 37345032 | PubTator, text mining | PubMed |
| The application and research progress of anti-angiogenesis therapy in tumor immunotherapy. | Front Immunol | 2023 | 37334350 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing reveals cell subpopulations in the tumor microenvironment contributing to hepatocellular carcinoma. | Front Cell Dev Biol | 2023 | 37333982 | PubTator, text mining | PubMed |
| Possible molecular mechanisms underlying the development of atherosclerosis in cancer survivors. | Front Cardiovasc Med | 2023 | 37332576 | PubTator, text mining | PubMed |
| Single cell and spatial sequencing define processes by which keratinocytes and fibroblasts amplify inflammatory responses in psoriasis. | Nat Commun | 2023 | 37308489 | PubTator, text mining | PubMed |
| Targeting transglutaminase 2 mediated exostosin glycosyltransferase 1 signaling in liver cancer stem cells with acyclic retinoid. | Cell Death Dis | 2023 | 37308486 | PubTator, text mining | PubMed |
| Target Therapy in Malignant Pleural Mesothelioma: Hope or Mirage? | Int J Mol Sci | 2023 | 37298116 | PubTator, text mining | PubMed |
| New Biomarkers and Treatment Advances in Triple-Negative Breast Cancer. | Diagnostics (Basel) | 2023 | 37296801 | PubTator, text mining | PubMed |
| Exploring the molecular mechanism of comorbidity of autism spectrum disorder and inflammatory bowel disease by combining multiple data sets. | J Transl Med | 2023 | 37291580 | PubTator, text mining | PubMed |
| Current progress in growth factors and extracellular vesicles in tendon healing. | Int Wound J | 2023 | 37291064 | PubTator, text mining | PubMed |
| Cancer immune exclusion: breaking the barricade for a successful immunotherapy. | Front Oncol | 2023 | 37284199 | PubTator, text mining | PubMed |
| A receptor-mediated landscape of druggable and targeted nanomaterials for gliomas. | Mater Today Bio | 2023 | 37273792 | PubTator, text mining | PubMed |
| Recent Advances in Therapeutic Modalities Against Breast Cancer-Related Lymphedema: Future Epigenetic Landscape. | Lymphat Res Biol | 2023 | 37267206 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/56034/papers?page=9